This is a preprint.
A trade-off between proliferation and defense in the fungal pathogen Cryptococcus at alkaline pH is controlled by the transcription factor GAT201
- PMID: 37398450
- PMCID: PMC10312749
- DOI: 10.1101/2023.06.14.543486
A trade-off between proliferation and defense in the fungal pathogen Cryptococcus at alkaline pH is controlled by the transcription factor GAT201
Abstract
Cryptococcus is a fungal pathogen whose virulence relies on proliferation in and dissemination to host sites, and on synthesis of a defensive yet metabolically costly polysaccharide capsule. Regulatory pathways required for Cryptococcus virulence include a GATA-like transcription factor, Gat201, that regulates Cryptococcal virulence in both capsule-dependent and capsule-independent ways. Here we show that Gat201 is part of a negative regulatory pathway that limits fungal survival at alkaline pH. RNA-seq analysis found strong induction of GAT201 expression within minutes of transfer to RPMI media at alkaline pH. Microscopy, growth curves, and colony forming unit assays show that in RPMI at alkaline pH wild-type Cryptococcus neoformans yeast cells produce capsule but do not bud or maintain viability, while gat201Δ cells make buds and maintain viability, yet fail to produce capsule. GAT201 is required for transcriptional upregulation of a specific set of genes, the majority of which are direct Gat201 targets. Evolutionary analysis shows that Gat201 is in a subfamily of GATA-like transcription factors that is conserved within pathogenic fungi but absent in model yeasts. This work identifies the Gat201 pathway as controlling a trade-off between proliferation and production of defensive capsule. The assays established here will allow characterisation of the mechanisms of action of the Gat201 pathway. Together, our findings urge improved understanding of the regulation of proliferation as a driver of fungal pathogenesis.
Figures







Similar articles
-
The GATA-like transcription factor Gat201 determines alkaline-restricted growth in Cryptococcus neoformans.mSphere. 2025 Jun 25;10(6):e0019125. doi: 10.1128/msphere.00191-25. Epub 2025 Jun 4. mSphere. 2025. PMID: 40464551 Free PMC article.
-
Unraveling Capsule Biosynthesis and Signaling Networks in Cryptococcus neoformans.Microbiol Spectr. 2022 Dec 21;10(6):e0286622. doi: 10.1128/spectrum.02866-22. Epub 2022 Oct 26. Microbiol Spectr. 2022. PMID: 36287085 Free PMC article.
-
A major role for capsule-independent phagocytosis-inhibitory mechanisms in mammalian infection by Cryptococcus neoformans.Cell Host Microbe. 2011 Mar 17;9(3):243-251. doi: 10.1016/j.chom.2011.02.003. Cell Host Microbe. 2011. PMID: 21402362 Free PMC article.
-
Connecting virulence pathways to cell-cycle progression in the fungal pathogen Cryptococcus neoformans.Curr Genet. 2017 Oct;63(5):803-811. doi: 10.1007/s00294-017-0688-5. Epub 2017 Mar 6. Curr Genet. 2017. PMID: 28265742 Free PMC article. Review.
-
The Cryptococcus neoformans capsule: a sword and a shield.Clin Microbiol Rev. 2012 Jul;25(3):387-408. doi: 10.1128/CMR.00001-12. Clin Microbiol Rev. 2012. PMID: 22763631 Free PMC article. Review.
References
-
- Andrews Simon, and et al.. 2010. “FastQC: A Quality Control Tool for High Throughput Sequence Data.” Babraham Bioinformatics, Babraham Institute, Cambridge, United Kingdom.
-
- Ballario P., Talora C., Galli D., Linden H., and Macino G.. 1998. “Roles in Dimerization and Blue Light Photoresponse of the PAS and LOV Domains of Neurospora Crassa White Collar Proteins.” Molecular Microbiology 29 (3): 719–29. - PubMed
-
- Ballou Elizabeth R., and Johnston Simon A.. 2017. “The Cause and Effect of Cryptococcus Interactions with the Host.” Current Opinion in Microbiology 40 (December): 88–94. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases